Septerna Balance Sheet
NASDAQ: SEPNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Septerna financial position
At the end of fiscal 2025, Septerna reported total assets of $596.2 million, up 30.6% from a year earlier against total liabilities of $214.3 million. Shareholders' equity stood at $381.9 million, or 64.1% of assets. The company held $120.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 4.73, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Septerna balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Cash & Equivalents | 120.72M | 238.20M | 88.48M |
| Short-Term Investments | 270.37M | 112.73M | 0 |
| Receivables | 10.36M | 171.00K | 151.00K |
| Total Current Assets | 410.96M | 356.82M | 112.68M |
| Property, Plant & Equipment | 4.43M | 5.09M | 4.67M |
| Long-Term Investments | 157.57M | 69.87M | 0 |
| Total Assets | 596.19M | 456.55M | 130.87M |
| Accounts Payable | 10.28M | 3.20M | 2.64M |
| Total Current Liabilities | 86.93M | 12.85M | 6.91M |
| Total Liabilities | 214.26M | 36.51M | 20.03M |
| Shareholders' Equity | 381.93M | 420.05M | -38.37M |
| Retained Earnings | -167.25M | -118.37M | -46.58M |
| Net Cash (Debt) | 391.09M | 350.92M | 88.48M |
| Shares Outstanding | 44.81M | 44.42M | 3.17M |
This table shows 3 annual periods of Septerna's balance sheet, from FY 2025 back to FY 2023, across 14 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow SEPN's reporting calendar. What is a balance sheet?